Maze (IPO)

Funding Details
Awarder
Inbox
Date Award
May 19, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Maze is focused on developing innovative treatments for kidney disease, leveraging advanced biotechnology to improve patient outcomes.
Market
Kidney Disease

Links
Back to Home Back to Biotechnology Deals View Funding Announcement